Society of Hospital Pharmacists

Society of Hospital Pharmacists
Name	Society of Hospital Pharmacists
Type	Professional association

Society of Hospital Pharmacists is a professional association representing pharmacists who work in hospital and health‑care settings. The organization provides clinical guidance, continuing professional development, standards of practice, and advocacy for medication safety across inpatient and outpatient services. It collaborates with universities, regulatory bodies, and health systems to integrate pharmacy practice into multidisciplinary care pathways.

History

The society traces its origins to national and regional efforts during the 20th century to professionalize hospital pharmacy alongside institutions such as Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, and Guy's Hospital. Early developments were influenced by events including the World War I and World War II which accelerated institutional pharmacy roles in military hospitals and Veterans Affairs systems such as the United States Department of Veterans Affairs. Pioneering figures in hospital pharmacy movements interacted with organizations like the American Pharmacists Association, Royal Pharmaceutical Society, and Pharmaceutical Society of Australia to establish training, formularies, and hospital pharmacy departments. Subsequent decades saw coordination with academic centers such as University of California, San Francisco, University of Toronto, King's College London, and Monash University to develop postgraduate programs and clinical pharmacy models. Milestones included the introduction of drug utilization review influenced by the Thalidomide tragedy and regulatory reforms involving agencies like the Food and Drug Administration and Medicines and Healthcare products Regulatory Agency.

Mission and Objectives

The society's stated mission aligns with professional norms advanced by bodies such as the World Health Organization, International Pharmaceutical Federation, and national health services including the National Health Service (England). Core objectives include improving inpatient medication safety, promoting pharmacovigilance in collaboration with agencies like the European Medicines Agency, advancing evidence‑based therapeutics in concert with members from institutions like Cleveland Clinic and Johns Hopkins School of Medicine, and supporting workforce development in partnership with accreditation entities such as the Accreditation Council for Pharmacy Education.

Membership and Organization

Membership categories mirror models used by the American Society of Health-System Pharmacists, Hospital Pharmacists Association of Australia, and the Canadian Society of Hospital Pharmacists, with tiers for student members from institutions such as Harvard University, University of Sydney, and University of Toronto, early career pharmacists, senior clinical pharmacists, and retired members. Governance structures follow common frameworks seen in organizations like Rotary International and Royal College of Physicians featuring boards, executive committees, and regional chapters that coordinate with local health authorities including NHS Scotland and state health departments in federated systems.

Professional Activities and Services

The society provides clinical guidance, formulary management tools, medication reconciliation programs, and antimicrobial stewardship initiatives paralleling efforts at Centers for Disease Control and Prevention and Infectious Diseases Society of America. It offers practice standards for sterile product preparation influenced by standards from United States Pharmacopeia and collaborates on multidisciplinary teams with professionals from institutions such as St. Thomas' Hospital, Mount Sinai Hospital, and Toronto General Hospital to improve transitions of care, oncology pharmacy services aligned with practices at Memorial Sloan Kettering Cancer Center, and critical care support modeled on protocols from Society of Critical Care Medicine.

Education, Training, and Certification

Educational programs include postgraduate diplomas, residency and fellowship placements patterned after the American Society of Health-System Pharmacists (ASHP) Residency Accreditation Program, and collaborative degrees with universities such as University of London, University of Melbourne, and McGill University. The society endorses certifications akin to board specialties offered by the Board of Pharmacy Specialties and supports continuing professional development through conferences and workshops similar to gatherings hosted by European Association of Hospital Pharmacists and specialty groups like the Oncology Nursing Society.

Research and Publications

Research priorities encompass pharmacotherapy, medication safety, health services research, and implementation science in line with journals and publishers such as The Lancet, British Medical Journal, New England Journal of Medicine, JAMA, and specialty titles like American Journal of Health-System Pharmacy. The society sponsors grants, collaborates with research institutes including the Wellcome Trust, National Institutes of Health, and university research centers, and disseminates findings through position statements, clinical guidelines, and peer‑reviewed articles that inform practices at hospitals like Royal Brisbane and Women's Hospital and Charité – Universitätsmedizin Berlin.

Advocacy and Policy Impact

Advocacy efforts engage with national legislatures, health ministries, and regulatory agencies such as the European Commission and Health Canada to influence policies on drug supply, medication safety, antimicrobial resistance strategies endorsed by the World Health Organization, and workforce planning referenced by entities like the Organisation for Economic Co-operation and Development. The society collaborates with patient safety organizations including Institute for Healthcare Improvement and participates in coalitions with professional bodies such as the Royal College of Pharmacy and international federations to shape reimbursement models, scope of practice regulations, and emergency preparedness policies in response to crises exemplified by the COVID-19 pandemic.

Category:Pharmacy organizations